R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

The transformation of brain implants

Nicolas Vachicouras, CEO of Neurosoft Bioelectronics, tells us how Neurosoft's electrode implant aims to reduce inflammation and scar tissue for patients, provide higher quality brain recor

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Webinars

The power of R&D collaborations to improve outcomes in rare ...

Far more common than initially thought, rare disease treatments remain far too scarce.

R&D

Novartis’ Amit Nastik on COVID’s supply chain impact: the ph...

Episode 41 of the pharmaphorum podcast heard from Amit Nastik about the impact of COVID-19 on pharma supply chains and how he and his team mitigated disruption to Novartis’ own operations.<

R&D

Treatment for all: the key steps to better representation in...

As people have become more conscious and vocal about diversity and inclusion, Page & Page’s Lisa Lishman says pharma should reassess how it conducts clinical trials.

R&D